0000000001217473

AUTHOR

Alex F Castro-mejía

showing 4 related works from this author

Underlying heart diseases and acute COVID-19 outcomes

2021

Background: The presence of any underlying heart condition could influence outcomes during the coronavirus disease 2019 (COVID-19). Methods: The registry HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19, NCT04334291) is an international ambispective study, enrolling COVID-19 patients discharged from hospital, dead or alive. Results: HOPE enrolled 2798 patients from 35 centers in 7 countries. Median age was 67 years (IQR: 53.0-78.0), and most were male (59.5%). A relevant heart disease was present in 682 (24%) cases. These were older, more frequently male, with higher overall burden of cardiovascular risk factors (hypertension, dyslipidemia, diabetes mellitus, smoking habit, …

Malemedicine.medical_specialtyHeart DiseasesHeart diseaseInfecciones por coronavirusEnfermedad cardiovascularEnfermedad transmisibleheart diseaseComorbidityregistry030204 cardiovascular system & hematologyGlobal HealthSepsis03 medical and health scienceschemistry.chemical_compound0302 clinical medicineTocilizumabRisk FactorsDiabetes mellitusInternal medicinemedicineHumansRegistriesPandemicsAgedRetrospective StudiesSARS-CoV-2business.industryCOVID-19HydroxychloroquineGeneral MedicineMiddle AgedPrognosismedicine.diseasemortalitychemistrycardiologyHeart failureCohortCardiologyFemaleCardiology and Cardiovascular MedicinebusinessDyslipidemiamedicine.drugCardiology Journal
researchProduct

Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 …

2021

Background The use of Renin-Angiotensin system inhibitors (RASi) in patients with coronavirus disease 2019 (COVID-19) has been questioned because both share a target receptor site. Methods HOPE-COVID-19 (NCT04334291) is an international investigator-initiated registry. Patients are eligible when discharged after an in-hospital stay with COVID-19, dead or alive. Here, we analyze the impact of previous and continued in-hospital treatment with RASi in all-cause mortality and the development of in-stay complications. Results We included 6503 patients, over 18 years, from Spain and Italy with data on their RASi status. Of those, 36.8% were receiving any RASi before admission. RASi patients were …

QA75Malemedicine.medical_specialtyHeart diseaseInfecciones por coronavirusmedicine.medical_treatmentInhibidores enzimáticosPopulationClinical InvestigationsEnfermedad transmisibleAngiotensin-Converting Enzyme InhibitorsSistema renina-angiotensinaComorbidity030204 cardiovascular system & hematologySeverity of Illness Index03 medical and health sciences0302 clinical medicineRisk FactorsOutcome Assessment Health CareSeverity of illnessmedicineHumansRegistries030212 general & internal medicineMedical prescriptioneducationHeart FailureMechanical ventilationeducation.field_of_studySARS-CoV-2business.industryCOVID-19Middle AgedPrognosismedicine.diseaseR1Respiration ArtificialComorbidityHospitalizationItalySpainHeart failureEmergency medicineFemaleObservational studyCardiology and Cardiovascular MedicinebusinessAmerican Heart Journal
researchProduct

Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19

2021

Gender-related differences in COVID-19 clinical presentation, disease progression, and mortality have not been adequately explored. We analyzed the clinical profile, presentation, treatments, and outcomes of patients according to gender in the HOPE-COVID-19 International Registry. Among 2,798 enrolled patients, 1,111 were women (39.7%). Male patients had a higher prevalence of cardiovascular risk factors and more comorbidities at baseline. After propensity score matching, 876 men and 876 women were selected. Male patients more often reported fever, whereas female patients more often reported vomiting, diarrhea, and hyposmia/anosmia. Laboratory tests in men presented alterations consistent w…

Malemedicine.medical_specialtyLeadership and ManagementAnosmiaComorbidityAssessment and DiagnosisCohort Studies03 medical and health sciencesSex Factors0302 clinical medicineHyposmiaInternal medicinemedicineHumans030212 general & internal medicine030223 otorhinolaryngologyCare PlanningAgedAged 80 and overbusiness.industryHealth PolicyCOVID-19General MedicineMiddle Agedmedicine.diseaseComorbidityHospitalizationSystemic inflammatory response syndromeHeart Disease Risk FactorsPropensity score matchingDisease ProgressionVomitingFemaleFundamentals and skillsmedicine.symptomLymphocytopeniabusinessCohort studyJournal of Hospital Medicine
researchProduct

[Atrial fibrillation in patients with COVID-19. Usefulness of the CHA

2021

Resumen Introduccion y objetivos La enfermedad por coronavirus de 2019 (COVID-19) esta causada por el segundo coronavirus del sindrome respiratorio agudo y grave. La fibrilacion auricular (FA) es comun en situaciones agudas, en las que conlleva mas complicaciones y mortalidad. Metodos Analisis del Registro internacional HOPE (NCT04334291); el objetivo es evaluar la informacion pronostica de FA en pacientes con COVID-19. Se realizo un analisis multivariable y un emparejamiento por puntuacion de propension para evaluar la relacion entre FA y mortalidad. Ademas, se evaluo en estos pacientes el impacto en la mortalidad y los eventos embolicos de la puntuacion CHA2DS2-VASc. Resultados Entre los …

PSM propensity score matchingRegistrymedicine.medical_specialtyAF atrial fibrillationArtículo Original030204 cardiovascular system & hematologyRisk AssessmentFibrilación auricular03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk FactorsHemorragiaInternal medicineHumansMedicineRegistriesMortalityStrokeEPP emparejamiento por puntuación de propensiónSARS-CoV-2business.industryIncidence (epidemiology)Mortality rateBleedingHazard ratioPronósticoCOVID-19Atrial fibrillationGeneral MedicinePrognosismedicine.diseaseAtrial fibrillationStrokeFA fibrilación auricularCHA2DS2-VAScPredictive value of testsMortalidadPropensity score matchingOriginal ArticleRegistroCardiology and Cardiovascular MedicinebusinessRisk assessmentHumanitiesRevista espanola de cardiologia
researchProduct